Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidanc...(61.3% Eliminations ...)

Eliminations (309.7) -3.5%

Pro Forma Combined Revenues 8,870.4 100.0%

Pre-merger Fisher Scientific

Results, Net of Eliminations (5,078.8)

GAAP Consolidated Revenues (a) $3,791.6

Pro Forma Operating Income and

Operating Margin (k)

Analytical Technologies $645.0 17.2%

Laboratory Products and Services 662.5 12.2%

Other/Eliminations (1.1)

Pro Forma Adjusted Combined

Operating Income (b) 1,306.4 14.7%

Pre-merger Fisher Scientific Results

Included Above (733.5)

Adjusted Operating Income (b) 572.9 15.1%

Cost of Revenues Charges (c) (77.7) -2.0%

Restructuring and Other Costs, Net

(d) (45.7) -1.2%

Equity Compensation Acceleration

Charge, Net of Tax (e) (36.7) -1.0%

Amortization of Acquisition-related

Intangible Assets (170.8) -4.5%

GAAP Operating Income (a) $242.0 6.4%

(a) "GAAP" (reported) results were determined in accordance with U.S.

generally accepted accounting principles (GAAP).

(b) Adjusted results are non-GAAP measures and exclude certain charges to

cost of revenues (see note (c) for details); amortization of

acquisition-related intangible assets; restructuring and other

costs, net (see note (d) for details); charges for the acceleration of

equity-based compensation expense in 2006 due to a change in control

(
'/>"/>